Biotricity, Inc.
BTCY
$0.6332
$0.00280.44%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.63% | 2.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.63% | 2.31% | |||
| Cost of Revenue | 4.53% | -15.28% | |||
| Gross Profit | 4.65% | 7.75% | |||
| SG&A Expenses | -34.42% | 36.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.20% | 20.33% | |||
| Operating Income | 132.95% | -406.21% | |||
| Income Before Tax | 65.28% | -57.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 65.28% | -57.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 65.28% | -57.48% | |||
| EBIT | 132.95% | -406.21% | |||
| EBITDA | 133.19% | -409.85% | |||
| EPS Basic | 62.58% | -40.99% | |||
| Normalized Basic EPS | 64.94% | -47.60% | |||
| EPS Diluted | 62.68% | -41.36% | |||
| Normalized Diluted EPS | 64.94% | -47.60% | |||
| Average Basic Shares Outstanding | -0.25% | 8.74% | |||
| Average Diluted Shares Outstanding | -0.25% | 8.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.79% | 0.34% | |||